UBE2C and metabolic dysfunction-associated steatohepatitis: Although the NASH-related etiology of HCCs showing overexpression of UBE2C has never been addressed in previous reports, the present study clearly demonstrated UBE2C DNA hypomethylation in both precancerous NASH and NASH-related HCCs (Fig. 2).